Skip to main content
SpringerLink
Log in

D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

[3H]SCH 23390 is a selective high affinity ligand for D1 receptors in vitro. Using this ligand persistent blockade of D1 receptors by SCH 23390 and cis-flupenthixol was shown to significantly increase the number of D1 receptor binding sites in rat striatum. In contrast, repeated administration of the D2-selective antagonist, clebopride, resulted in a small, but significant, reduction in number. No differences in binding affinity were observed and a single dose of these compounds was without effect. The D2-selective antagonist, haloperidol, the non-selective D1/D2 receptor antagonist, chlorpromazine, the dopamine reuptake inhibitors, bupropion, GBR 12909 and nomifensine, and the dopamine releasing agent, d-amphetamine, had no effect on D1 receptors. The antidepressant treatments, desipramine, zimeldine, amitriptyline, tranylcypromine, mianserin and ECS and the monoamine reuptake inhibitor, sibutramine, similarly did not alter striatal D1 sites. Thus, of the treatments investigated only chronic receptor blockade by high affinity antagonists altered D1 receptor binding in rat striatum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andersen PH (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166: 493–504

    Google Scholar 

  • Andersen PH, Grønvald FC, Jansen JA (1985) A comparison between dopamine-stimulated adenylate cyclase and3H-SCH 23390 binding in rat striatum. Life Sci 37: 1971–1983

    Google Scholar 

  • Baldessarini RJ, Frankenburg FR (1991) Clozapine a novel antipsychotic agent. N Engl J Med 324: 746–754

    Google Scholar 

  • Barkai AI, Durkin M, Nelson HD (1990) Localized alterations of dopamine receptor binding in rat brain by repeated electroconvulsive shock: an autoradiographic study. Brain Res 529: 208–213

    Google Scholar 

  • Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A (1984) Characterization of the binding of3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci 35: 1885–1893

    Google Scholar 

  • Bowden C, Cheetham SC, Crompton MR, Katona CLE, de Paermentier F, Theodorou AE, Horton RW (1994a) Dopamine and its metabolites in depressed suicide victims. Can J Physiol Pharmacol 72(1): T 13.11.26

    Google Scholar 

  • Bowden C, Cheetham SC, Crompton MR, Katona CLE, de Paermentier F, Theodorou AE, Horton RW (1994b) Dopamine D1 and D2 receptor binding sites in depressed suicide victims. Br J Pharmacol 110: 2P

  • Cheetham SC, Viggers JA, Slater NA, Buckett WR (1990) Inhibition of [3H]paroxetine binding by sibutramine, its metabolites and other antidepressants correlates with inhibition of [3H]5-hydroxytryptamine uptake. Br J Pharmacol 101: 515P

  • Cheng Y-C, Prusoff WH (1973) Relationship between inhibition constant (Ki) and the concentration of the inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099–3108

    Google Scholar 

  • Chipkin RE, Iorio LC, Coffin VL, McQuade RD, Berger JG, Barnett A (1988) Pharmacological profile of SCH 39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity. J Pharmacol Exp Ther 247: 1093–1102

    Google Scholar 

  • Creese I, Chen A (1985) Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390. Eur J Pharmacol 109: 127–128

    Google Scholar 

  • De Montis GM, Devoto P, Gessa GL, Meloni D, Porcella A, Saba P, Serra G, Tagliamonte A (1990) Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. Eur J Pharmacol 180: 31–35

    Google Scholar 

  • Faedda G, Kula NS, Baldessarini RJ (1989) Pharmacology of binding of3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue. Biochem Pharmacol 38: 473–480

    Google Scholar 

  • Fleminger S, Rupniak NMJ, Hall MD, Jenner P, Marsden CD (1983) Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not increases in D-1 receptors. Biochem Pharmacol 32: 2921–2927

    Google Scholar 

  • Globus M, Lerer B, Hamburger R, Belmaker RH (1981) Chronic electroconvulsive shock and chronic haloperidol administration are not additive in effects on dopamine receptors. Neuropharmacology 20: 1125–1128

    Google Scholar 

  • Green AR, Heal DJ, Grahame-Smith DG (1977) Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology 52: 195–200

    Google Scholar 

  • Heal DJ, Butler SA, Hurst EM, Buckett WR (1989) Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease β1 but not β2-adrenoceptors in rat cortex. J Neurochem 53: 1019–1025

    Google Scholar 

  • Heal DJ, Czudek C, Buckett WR (1994) Common profile of D1 receptor antagonists and atypical antipsychotic drugs revealed by analysis of dopamine turnover. Prog Neuropsychopharmacol Biol Psychiatry 18: 803–821

    Google Scholar 

  • Heal DJ, Prow MR, Buckett WR (1991) Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic α2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride. Psychopharmacology 103: 251–257

    Google Scholar 

  • Hyttel J (1983) SCH 23390 – the first selective dopamine D-1 antagonist. Eur J Pharmacol 91: 153–154

    Google Scholar 

  • Hyttel J (1986) Effect of prolonged treatment with neuroleptics on D-1 and D-2 receptor number in corpus striatum of rat and mouse. Acta Pharmacol Toxicol Copenh 59: 387–391

    Google Scholar 

  • Hyttel J, Arnt J (1987) Characterization of binding of3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions. J Neural Transm 68: 171–189

    Google Scholar 

  • Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226: 462–468

    Google Scholar 

  • Jenner P, Marsden CD (1981) Substituted benzamide drugs as selective neuroleptic agents. Neuropharmacology 20: 1285–1293

    Google Scholar 

  • Kerkman DJ, Ackerman M, Artman LD, MacKenzie RG, Johnson MC, Bednarz L, Montana W, Asin KE, Stampfli H, Kebabian JW (1989) A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor. Eur J Pharmacol 166: 481–491

    Google Scholar 

  • Klimek V, Nielsen M (1987) Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system. Eur J Pharmacol 139: 163–169

    Google Scholar 

  • Laruelle M, Jaskiw GE, Lipska BK, Kolachana B, Casanova MF, Kleinman JE, Weinberger DR (1992) D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment. Brain Res 575: 47–56

    Google Scholar 

  • Lévesque D, Diaz J, Pilon C, Martres M-P, Giros B, Souil E, Schott D, Morgat J-L, Schwartz J-C, Sokoloff P (1992) Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89: 8155–8159

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275

    Google Scholar 

  • Martin KF, Needham PL, Atkinson J, Cowan A, Heal DJ, Buckett WR (1988) Rat striatal and mesolimbic D1 receptor binding is not altered by antidepressant treatments including ECS and sibutramine HCl. Br J Pharmacol 95: 896P

  • Matsubara S, Matsubara R, Kusumi I, Koyama T, Yamashita I (1993) Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J Pharmacol Exp Ther 265: 498–508

    Google Scholar 

  • McGonigle P, Boyson SJ, Reuter S, Molinoff PB (1989) Effect of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. Synapse 3: 74–82

    Google Scholar 

  • McPherson GA (1983) A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed 17: 107–113

    Google Scholar 

  • Meller E, Bohmaker K, Goldstein M, Friedhoff AJ (1985) Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics. J Pharmacol Exp Ther 233: 656–662

    Google Scholar 

  • Modigh K (1975) Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS. J Neural Transm 36: 19–32

    Google Scholar 

  • Munson PJ, Rodbard D (1980) LIGAND: a versatile computerised approach for characterisation of ligand-binding systems. Anal Biochem 107: 220–239

    Google Scholar 

  • Nowak G, Zak J (1989) Repeated electroconvulsive shock (ECS) enhances striatal D-1 dopamine receptor turnover in rats. Eur J Pharmacol 167: 307–308

    Google Scholar 

  • O'Boyle KM, Gaitanopoulos DE, Brenner M, Waddington JL (1989) Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor. Neuropharmacology 28: 401–405

    Google Scholar 

  • Paetsch PR, Greenshaw AJ (1992) Effects of chronic antidepressant treatment on dopaminerelated [3H]SCH 23390 and [3H]spiperone binding in the rat striatum. Cell Mol Neurobiol 12: 597–606

    Google Scholar 

  • Porceddu ML, Ongini E, Biggio G (1985) [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors. Eur J Pharmacol 118: 367–370

    Google Scholar 

  • Rudorfer MV, Potter WZ (1989) Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the “newer” versus the “older” drugs. Drugs 37: 713–738

    Google Scholar 

  • Sharp T, Kingston J, Grahame-Smith DG (1990) Repeated ECS enhances dopamine D-1 but not D-2 agonist-induced behavioural responses in rats. Psychopharmacology 100: 110–114

    Google Scholar 

  • Stoof JC, Kebabian JW (1981) Opposing roles for the D-1 and D-2 dopamine receptors in efflux of cAMP from rat neostriatum. Nature 294: 366–368

    Google Scholar 

  • Stoof JC, Verheijden PFHM (1986) D-2 receptor stimulation inhibits cyclic AMP formation brought about by D-1 receptor stimulation in rat neostriatum but not nucleus accumbens. Eur J Pharmacol 129: 205–206

    Google Scholar 

  • Sunahara RK, Guan H-C, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HHM, Niznik HB (1991) Cloning of the gene for a human dopamine D5receptor with higher affinity for dopamine than D1. Nature 350: 614–619

    Google Scholar 

  • Van Tol HHM, Bunzow JR, Guan H-C, Sunahara RK, Seeman P, Niznik HB, Civelli O (1991) Cloning of the gene for a human D4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610–614

    Google Scholar 

  • Von Voigtlander PF, Moore KE (1973) Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine. J Pharmacol Exp Ther 184: 542–552

    Google Scholar 

  • Weintraub M, Rubio A, Golik A, Byrne L, Scheinbaum ML (1991) Sibutramine in weight control: a dose-ranging, efficacy study. Clin Pharmacol Ther 50: 330–337

    Google Scholar 

  • Wielosz M (1981) Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats. Neuropharmacology 20: 941–945

    Google Scholar 

Download references

Author information

Author notes

  1. S. C. Cheetham

    Present address: Boots Pharmaceuticals Research Department, Nottingham, UK

Authors and Affiliations

  1. Boots Pharmaceuticals Research Department, Nottingham, UK

    C. J. Kettle, K. F. Martin & D. J. Heal

Authors
  1. S. C. Cheetham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. J. Kettle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. F. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. J. Heal
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheetham, S.C., Kettle, C.J., Martin, K.F. et al. D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function. J. Neural Transmission 102, 35–46 (1995). https://doi.org/10.1007/BF01276563

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01276563

Keywords

Search

Navigation